Creatinine Clearance and Statins in Diabetes (Erin)

Diabetes: Setting Goals and Initiating Therapy
0.5 ANCC Contact Hours 0.5 AMA PRA Category 1 Credit(s)
Launch Date:
June 11, 2014
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Family practitioners, primary care physicians, endocrinologists, nurse practitioners, physician's assistants, and nurses with an interest in diabetes.

Relevant Terms:


Frank Lavernia, MD

Frank Lavernia, MD
Founder of the North Broward Diabetes Center
Coconut Creek, FL

Dr. Frank Lavernia is founder of the North Broward Diabetes Center in Coconut Creek, Florida. With specific interest in diabetes mellitus, hypertension, and lipid management, Dr. Lavernia has over 32 years of experience in diabetes practice, and is a national speaker for educational programs all over the US.
Dr. Lavernia attended Northwestern University in Evanston, IL and received his medical degree from Zaragoza Medical School in Zaragoza, Spain. He has been a faculty member of the National Diabetes Education Initiative (NDEI), Vascular Biology Working Group (VBWG), and Coalition for the Advancement of Cardiovascular Health (COACH) for many years, and his office has held a Certificate of Recognition from the American Diabetes Association (ADA) and National Committee of Quality Assurance (NCQA) since 1998.
Dr. Lavernia is a member of the ADA and the National Hispanic Medical Association. He has multiple publications and has appeared in several TV programs and NPR (National Public Radio) discussing diabetes and its complications.
1. Discuss the frequency of measuring renal function in patients with diabetes, and caveats for treatment in patients with impaired renal function
2. Discuss recent research surrounding when it is appropriate to add a statin to the regimen of a patient with diabetes

Erin: Creatinine Clearance and Statins in Diabetes
*Please note that participation in this activity is available for CME and CNE credits only. MOC credits will not be granted solely for participation in these online activities. MOC credit is only available to those participating in a private program that includes two additional QI components.
Frank Lavernia, MD
Founder of the North Broward Diabetes Center
Coconut Creek, FL
This PI-CME program is designed to meet the educational needs of primary care physicians, endocrinologists, diabetologists, nurses, pharmacists, and other healthcare practitioners involved in the treatment of patients with type 2 diabetes.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
Med Learning Group will designate a maximum of 0.5 AMA PRA Category 1 Credits™ for this case study.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
This program would be beneficial for nurses involved in the management of patients with diabetes and would help them to implement an individualized plan for their patients.
CNE Credits:
Each activity is accredited for 0.5 ANCC Contact Hour(s)
CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 0.5 contact hour(s) of continuing nursing education of RNs and APNs per activity.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Dr. Lavernia is on the advisory boards for Sanofi, Eli Lilly, and Janssen. He is a member of the Speaker's Bureau for Janssen.
MLG Course Reviewer
Katherine Galluzzi, DO, CMD, FACOFP dist.
Professor and Chairperson, Department of Geriatrics
Philadelphia College of Osteopathic Medicine
Attending Physician, Family Medicine
Tenet Roxborough Memorial Hospital
Philadelphia, Pennsylvania
UMA/CCM Nurse Reviewer
Margaret Governo, EdD, APRN BC
CCM Lead Nurse Planner
Ultimate Medical Academy
MLG Course Reviewer - - Dr. Katherine Galluzzi has no relevant financial relationships to disclose.
CCM/UMA Lead Nurse Planner - - Margaret Governo, EdD, APRN BC has disclosed no significant financial relationships.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, Vice President of Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Chris Drury, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, Dr. Lavernia may mention the use of medications for both FDA-approved and non-approved indications
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
  1. Read the CME/CNE information and faculty disclosures.
  2. Participate in the enduring activity.
  3. Submit the evaluation form to the Med Learning Group.
You will receive your certificate via email within 30 days.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at:
Sponsored by Med Learning Group
This activity was co-provided by Ultimate Medical Academy/CCM.
This activity is supported by an educational grant from Lilly USA, LLC and Takeda Pharmaceuticals International, Inc., US Region.
Participation Statement
This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields. This subsidy is reflected in the registration fees for this activity.
 Copyright © 2014 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above

For video playback, install the latest version of Flash or Quicktime.
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above